Hepa Life Biosystems Inc is categorized under Biotechnology Products and Services in New York City, NY .
Hepa Life Biosystems Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Richard Rosenblum, President at the company’s single location by writing to 850 3rd Avenue # 1801, New York City, New York NY 10022 or by phoning (646) 218-1450. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Hepa Life Biosystems Inc |
Contact Person: | Richard Rosenblum, President |
Address: | 850 3rd Avenue # 1801, New York City, New York 10022 |
Phone Number: | (646) 218-1450 |
Annual Revenue (USD): | Unknown |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Biotechnology Products and Services |
SIC Code: | 8731 |
NAICS Code: | 5417114 |
Share This Business: |
Hepa Life Biosystems Inc was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Richard Rosenblum, President for inquiries that concern Hepa Life Biosystems Inc by calling the company number (646) 218-1450, as your correspondence is most welcome. Additionally, the physical location of the single location of Hepa Life Biosystems Inc can be found at the coordinates 40.756939,-73.970032 as well as the street address 850 3rd Avenue # 1801 in New York City, New York 10022.
For its online presence, you may visit Hepa Life Biosystems Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.